IN2014CN03968A - - Google Patents
Info
- Publication number
- IN2014CN03968A IN2014CN03968A IN3968CHN2014A IN2014CN03968A IN 2014CN03968 A IN2014CN03968 A IN 2014CN03968A IN 3968CHN2014 A IN3968CHN2014 A IN 3968CHN2014A IN 2014CN03968 A IN2014CN03968 A IN 2014CN03968A
- Authority
- IN
- India
- Prior art keywords
- chain variable
- variable region
- antigens
- polypeptide containing
- fluorochrome
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
- G01N33/533—Production of labelled immunochemicals with fluorescent label
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
- G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
- G01N33/946—CNS-stimulants, e.g. cocaine, amphetamines
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
- G01N33/948—Sedatives, e.g. cannabinoids, barbiturates
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
- G01N33/9486—Analgesics, e.g. opiates, aspirine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/55—Fab or Fab'
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/94—Stability, e.g. half-life, pH, temperature or enzyme-resistance
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
- G01N2021/6432—Quenching
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
- G01N33/6857—Antibody fragments
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Optics & Photonics (AREA)
- Virology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Tropical Medicine & Parasitology (AREA)
- Anesthesiology (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2011241402 | 2011-11-02 | ||
PCT/JP2012/007025 WO2013065314A1 (fr) | 2011-11-02 | 2012-11-01 | Procédé de dosage fluoro-immunologique faisant appel à un complexe polypeptidique contenant une région variable d'anticorps fluoromarquée |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2014CN03968A true IN2014CN03968A (fr) | 2015-10-23 |
Family
ID=48191686
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN3968CHN2014 IN2014CN03968A (fr) | 2011-11-02 | 2012-11-01 |
Country Status (8)
Country | Link |
---|---|
US (1) | US20140329228A1 (fr) |
EP (1) | EP2775305A4 (fr) |
JP (2) | JP5817838B2 (fr) |
KR (1) | KR101603456B1 (fr) |
CN (1) | CN103917872B (fr) |
CA (1) | CA2854432A1 (fr) |
IN (1) | IN2014CN03968A (fr) |
WO (1) | WO2013065314A1 (fr) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2015062365A (ja) * | 2013-09-25 | 2015-04-09 | Necソリューションイノベータ株式会社 | ラクトパミンに結合する核酸分子およびその用途 |
JP2015062364A (ja) * | 2013-09-25 | 2015-04-09 | Necソリューションイノベータ株式会社 | クレンブテロールに結合する核酸分子およびその用途 |
WO2015122484A1 (fr) * | 2014-02-13 | 2015-08-20 | ウシオ電機株式会社 | Procédé d'extraction de constituant de cannabis, dispositif de contrôle de constituant de cannabis et procédé de contrôle de constituant de cannabis |
EP3633378A1 (fr) * | 2014-04-15 | 2020-04-08 | Cézanne S.A.S. | Dosage immunologique pour le diagnostic, l'évaluation des risques, la stratification des risques, le contrôle de thérapie et / ou le contrôle post-opération d'une tumeur neuroendocrine ou d'un cancer de la prostate |
JP5949890B2 (ja) * | 2014-12-24 | 2016-07-13 | ウシオ電機株式会社 | 蛍光標識された抗体可変領域を含むポリペプチドを含む抗原結合タンパク質を用いた蛍光免疫測定方法 |
JP6473366B2 (ja) * | 2015-03-31 | 2019-02-20 | シスメックス株式会社 | 温度判定方法、標的ペプチドの検出方法および温度判定試薬 |
JP6921002B2 (ja) * | 2015-05-11 | 2021-08-18 | ヤンセン ファッシンズ アンド プリベンション ベーフェーJanssen Vaccines & Prevention B.V. | ペプチド模倣化合物を中和するインフルエンザウイルス |
WO2016208466A1 (fr) * | 2015-06-22 | 2016-12-29 | ウシオ電機株式会社 | Procédé de détection d'une substance d'intérêt |
JP2017020896A (ja) * | 2015-07-10 | 2017-01-26 | 国立大学法人北陸先端科学技術大学院大学 | N末端標識剤、これを用いた蛍光標識タンパク質及びその製造方法 |
WO2017034925A1 (fr) * | 2015-08-25 | 2017-03-02 | Bio-Rad Laboratories, Inc. | Dosage immunologique numérique |
JP2017049184A (ja) * | 2015-09-03 | 2017-03-09 | 国立大学法人東京工業大学 | 抗体のヌクレオチド結合部位(nbs)を利用して蛍光標識された抗体 |
JP6885595B2 (ja) * | 2015-12-04 | 2021-06-16 | 国立大学法人 東京大学 | リガンド蛍光センサータンパク質とその使用 |
CN105647918A (zh) * | 2016-02-20 | 2016-06-08 | 深圳市圣必智科技开发有限公司 | 抗乙肝e抗原的红色荧光抗体的制备方法 |
KR101847264B1 (ko) * | 2016-03-29 | 2018-04-10 | 국립암센터 | 항원 반응형 항체-형광염료 결합체 및 이를 이용한 표적 세포의 형광영상 검출방법 |
CN107044888B (zh) * | 2017-03-17 | 2019-03-01 | 同济大学 | 基于荧光染料ThT、RET基因的温度计的构建方法 |
WO2018211126A1 (fr) | 2017-05-19 | 2018-11-22 | Philip Morris Products S.A. | Test de diagnostic pour distinguer le statut de fumeur d'un sujet |
WO2020026733A1 (fr) * | 2018-07-30 | 2020-02-06 | 国立大学法人東京工業大学 | Anticorps ou fragment d'anticorps marqués par fluorescence |
US20220244248A1 (en) | 2019-06-05 | 2022-08-04 | Tokyo Institute Of Technology | Homogeneous immunoassay method using peptide having multiple fluorochromes joined thereto |
CN114057881B (zh) * | 2021-12-28 | 2023-10-13 | 杭州贤至生物科技有限公司 | 抗氯胺酮特异性抗体、质粒载体及方法 |
CN117659201A (zh) * | 2022-08-23 | 2024-03-08 | 东莞市朋志生物科技有限公司 | 抗可卡因抗体或其功能性片段、检测可卡因的试剂和试剂盒 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH02195256A (ja) * | 1989-01-24 | 1990-08-01 | Matsushita Electric Ind Co Ltd | 免疫的検出方法および装置 |
US5643722A (en) | 1994-05-11 | 1997-07-01 | Trustees Of Boston University | Methods for the detection and isolation of proteins |
JP3784111B2 (ja) | 1996-07-31 | 2006-06-07 | ロシュ ダイアグノスティックス コーポレーション | 抗原濃度測定方法 |
JPH10282098A (ja) | 1997-04-11 | 1998-10-23 | Matsushita Electric Ind Co Ltd | 蛍光免疫測定法 |
JP4193249B2 (ja) | 1998-11-11 | 2008-12-10 | 三菱化学株式会社 | C末端がラベル化されたタンパク質の製造方法 |
WO2001061351A1 (fr) * | 2000-02-17 | 2001-08-23 | Laboratory Of Molecular Biophotonics | Detection d'antigene par voie quantitative |
JP4266367B2 (ja) * | 2002-09-19 | 2009-05-20 | 浜松ホトニクス株式会社 | 蛍光化抗体を用いた蛍光分析方法 |
CN100473988C (zh) * | 2004-07-08 | 2009-04-01 | 厦门大学 | 具有荧光共振能量转移特点的蛋白组合及其用途 |
WO2007033514A1 (fr) * | 2005-09-19 | 2007-03-29 | Xiamen University | Combinaison de protéines caractérisée dans le transfert d'énergie entre molécules fluorescentes et utilisation de cette combinaison de protéines |
WO2009021026A1 (fr) * | 2007-08-06 | 2009-02-12 | University Of Kentucky Research Foundation | Anticorps semi-synthetiques utilises en tant qu'elements de reconnaissance |
WO2009154026A1 (fr) * | 2008-06-20 | 2009-12-23 | 国立大学法人岡山大学 | Anticorps dirigé contre le globule calcifié et son utilisation |
JP2011095085A (ja) * | 2009-10-29 | 2011-05-12 | Hipep Laboratories | プリオンの測定方法 |
CN102667480B (zh) * | 2009-11-19 | 2014-08-20 | 优志旺电机株式会社 | 荧光免疫测定方法 |
-
2012
- 2012-11-01 IN IN3968CHN2014 patent/IN2014CN03968A/en unknown
- 2012-11-01 EP EP12846408.8A patent/EP2775305A4/fr not_active Withdrawn
- 2012-11-01 CN CN201280053916.2A patent/CN103917872B/zh active Active
- 2012-11-01 US US14/355,705 patent/US20140329228A1/en not_active Abandoned
- 2012-11-01 CA CA2854432A patent/CA2854432A1/fr not_active Abandoned
- 2012-11-01 KR KR1020147013914A patent/KR101603456B1/ko active IP Right Grant
- 2012-11-01 WO PCT/JP2012/007025 patent/WO2013065314A1/fr active Application Filing
- 2012-11-01 JP JP2013541635A patent/JP5817838B2/ja active Active
-
2015
- 2015-05-29 JP JP2015110229A patent/JP6070769B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
JPWO2013065314A1 (ja) | 2015-04-02 |
EP2775305A1 (fr) | 2014-09-10 |
JP2015193631A (ja) | 2015-11-05 |
US20140329228A1 (en) | 2014-11-06 |
KR20140084266A (ko) | 2014-07-04 |
WO2013065314A1 (fr) | 2013-05-10 |
EP2775305A4 (fr) | 2015-06-24 |
CA2854432A1 (fr) | 2013-05-10 |
CN103917872A (zh) | 2014-07-09 |
KR101603456B1 (ko) | 2016-03-14 |
CN103917872B (zh) | 2016-05-18 |
JP5817838B2 (ja) | 2015-11-18 |
JP6070769B2 (ja) | 2017-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IN2014CN03968A (fr) | ||
Chen et al. | SERS-based dual-mode DNA aptasensors for rapid classification of SARS-CoV-2 and influenza A/H1N1 infection | |
WO2011061944A8 (fr) | Procédé de dosage fluoroimmunologique | |
IN2014MN01572A (fr) | ||
EA201490999A1 (ru) | Способ проведения количественных анализов | |
BR112014032930A2 (pt) | coleta de amostra e sistema de análise bioluminescente | |
EA201290311A1 (ru) | Факторы риска и прогнозирование инфаркта миокарда | |
WO2013132347A3 (fr) | Immunodosage elisa amélioré de la calprotectine | |
SE0800724L (sv) | Blodviskositetsanalys | |
Song et al. | Highly sensitive paper-based immunoassay using photothermal laser speckle imaging | |
EP3575781A3 (fr) | Bandes de test et procédé de lecture de bandes de test | |
BR112015011040A2 (pt) | calibração de testes usando tempo de reação | |
WO2019118971A8 (fr) | Dispositifs de mesure biomédicaux, systèmes et procédés de mesure de concentration de peptide pour surveiller un état pathologique | |
RU2016107649A (ru) | Способ и система для датчика кислорода | |
MX2018001134A (es) | Aparato y metodo de deteccion de gas. | |
EP2585832A4 (fr) | Réduction de faux résultats dans des mesures de dosage | |
Zhang et al. | Quantitative and rapid detection of microcystin-LR using time-resolved fluorescence immunochromatographic assay based on europium nanospheres | |
WO2014054389A8 (fr) | Procédé de dosage immunologique faisant appel aux plasmons de surface | |
WO2013068320A3 (fr) | Appareil et procédé de détermination des quantités de deux substances ou plus présentes dans un liquide | |
CN104949943A (zh) | 一种生物样品快速检测方法 | |
EA202090630A1 (ru) | Устройство для анализа и способ анализа | |
IN2012DN05912A (fr) | ||
WO2016100117A3 (fr) | Mesure précise de type dosage d'analytes hapténiques hydrophobes | |
CN104237230A (zh) | 褪黑素的快速检测方法及其操作器皿组合 | |
FI20115285A0 (fi) | Menetelmä pikatestin suorittamiseksi |